Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Filament Health shipped PEX010 to the University of Calgary for the Phase 2 PsiPTSD study targeting adult survivors of intimate partner violence.
Rhelion Life Sciences' Filament Health has shipped PEX010 botanical psilocybin to Bruyère Health Research Institute for a Phase 3 trial targeting 120 participants in palliative care across seven Canadian sites.
Filament delivered PEX010 to Bruyère Health Research Institute for a Phase 3, placebo-controlled microdose psilocybin trial in palliative care across seven Canadian sites.